Medicare Enrolled
Dr. Christopher Payne, MD
Urology Physician · Texarkana, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Payne from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Payne?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Payne
Dr. Christopher Payne is an urology physician in Texarkana, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Payne performed 5,993 Medicare services across 4,147 unique beneficiaries.
Between the years covered by Open Payments, Dr. Payne received a total of $2,797 from 36 pharmaceutical and/or device companies across 139 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Payne is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 18% volume in TX
$2,797 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,993
Medicare services
Top 18% in TX for urology physician
4,147
Unique beneficiaries
$40
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~300 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
1,430 | $3 | $28 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,119 | $60 | $175 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
664 | $8 | $20 |
| PSA test (prostate cancer screening) | 567 | $18 | $79 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 372 | $134 | $450 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
308 | $8 | $75 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
216 | $19 | $57 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
162 | $73 | $214 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
159 | $173 | $445 |
| Urine culture, bacterial identification A laboratory test that grows and identifies bacteria from a urine sample to detect infections. |
117 | $8 | $42 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
102 | $92 | $245 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
94 | $9 | $42 |
| Bacterial culture, aerobic A laboratory test that grows and identifies bacteria capable of surviving in oxygen. The results help determine the presence of specific aerobic microorganisms. |
75 | $8 | $40 |
| Antibiotic sensitivity test A laboratory test that determines which antibiotics, antifungals, or antivirals are effective against a specific microorganism using microdilution or agar dilution methods. |
75 | $8 | $58 |
| PSA test (prostate cancer screening) A blood test that measures the level of prostate-specific antigen to screen for prostate cancer. |
75 | $19 | $79 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
59 | $26 | $63 |
| Imaging of urinary tract with contrast An imaging test of the urinary tract performed after a contrast agent is injected to enhance visibility of the structures. |
48 | $19 | $40 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
44 | $101 | $255 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
33 | $109 | $315 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
27 | $97 | $495 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
27 | $23 | $68 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
26 | $317 | $2,050 |
| Abdominal X-ray, 2 views An X-ray imaging test of the abdomen using two different angles to visualize internal structures. |
24 | $25 | $59 |
| Injection, garamycin, gentamicin, up to 80 mg | 24 | $2 | $14 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
22 | $24 | $105 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
19 | $92 | $1,711 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
19 | $561 | $2,100 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
19 | $5 | $28 |
| Blood urea nitrogen test A blood test that measures the amount of urea nitrogen to assess kidney function. |
16 | $4 | $24 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
15 | $32 | $110 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
13 | $15 | $44 |
| Ureteral stone crushing with endoscope A procedure to break up a stone in the ureter using an endoscope. The endoscope is inserted to locate and crush the stone. |
12 | $248 | $2,023 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
11 | $106 | $350 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.8% high complexity
10.0% medium
89.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,797
Total received (2018-2024)
Avg $400/year across 7 years
Bottom 47% in TX for urology physician
36
Companies
139
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,697 (96.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$100 (3.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$601
2023
$553
2022
$223
2021
$113
2020
$72
2019
$597
2018
$637
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Astellas Pharma US Inc
$478
Boston Scientific Corporation
$269
ABBVIE INC.
$235
Sumitomo Pharma America, Inc.
$167
Axonics, Inc.
$158
NeoTract Inc.
$117
Teleflex LLC
$107
PROCEPT BioRobotics Corporation
$104
Janssen Products, LP
$100
PFIZER INC.
$94
UROVANT SCIENCES INC
$90
Melinta Therapeutics, Inc.
$82
Janssen Biotech, Inc.
$76
AbbVie, Inc.
$75
180 Medical, Inc.
$70
Ferring Pharmaceuticals Inc.
$68
GlaxoSmithKline, LLC.
$53
Blue Earth Diagnostics Limited
$52
Medtronic, Inc.
$40
UROGEN PHARMA, INC.
$34
Avadel Specialty Pharmaceuticals, LLC
$31
Allergan, Inc.
$29
ACCORD HEALTHCARE, INC.
$28
Augmenix, Inc.
$28
Antares Pharma, Inc.
$23
Bayer HealthCare Pharmaceuticals Inc.
$22
Endo USA, Inc.
$20
Ambu Inc.
$20
Myovant Sciences Inc.
$19
Siemens Medical Solutions USA, Inc.
$18
Cook Medical LLC
$15
C. R. BARD, INC. & SUBSIDIARIES
$15
Laborie Medical Technologies Corp.
$15
UroGen Pharma, Inc.
$15
Tolmar, Inc.
$14
Accord Healthcare, Inc.
$12
Top 3 companies account for 35.1% of total payments
Associated products mentioned in payments ›
ADSTILADRIN · AMS · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Axonics · Axonics r-SNM System · Axumin · BEXSERO · BOTOX · Bulkamid · CAMCEVI · COOK · ELIGARD · Erleada · GEMTESA · GENERAL FEMALE SUI · INTERSTIM · JELMYTO · LITHOVUE · LUPRON DEPOT · Lupron · Lupron Depot · MYRBETRIQ · Myrbetriq · NOCDURNA · Noctiva · ORGOVYX · Optilume BPH Drug Coated Balloon Catheter · POSLUMA · Rezum Generator · SELF-CATH · SPACEOAR · SpaceOAR · UROLIFT · UroLift · Uroskop Omnia Max · VESICARE · Vabomere · Veozah · XTANDI · Xofigo · ZYTIGA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $47 per 100 Medicare services performed
Geographic Context
Urology physicians within 10 mi
7
Per 100K population
7.6
County median income
$59,295
Nearest hospital
CHRISTUS ST MICHAEL HEALTH SYSTEM
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Payne is a clinical cardiology specialist, with above-average Medicare volume (top 18% in TX), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Payne experienced with urinalysis with microscopic exam?
Based on Medicare claims data, Dr. Payne performed 1,430 urinalysis with microscopic exam services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Payne receive payments from pharmaceutical companies?
Yes. Dr. Payne received a total of $2,797 from 36 companies across 139 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Payne's costs compare to other urology physicians in Texarkana?
Dr. Payne's average Medicare payment per service is $40. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Payne) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Texarkana
Browse urology physicians in Texarkana ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology